Furthermore, CXCR2 has been identified as an adverse prognostic factor for MDS/AML, suggesting that the CXCL8/CXCR2 axis likely plays a crucial role in AML/MDS. The gene discussed is CXCL8; the disease is acute myeloid leukemia.